The Europe hyaluronic acid based dermal fillers market size
is expected to reach USD 1.4 billion by 2026, according to a new report by
Grand View Research Inc., exhibiting a CAGR of 7.6% over the forecast
period. Rapidly aging population, large number of cosmetic surgeries
performed, and technological advancements are among key factors driving the
market. Growing demand to enhance one’s aesthetic appeal is resulting in high
number of cosmetic surgeries being performed. This can also be attributed to
the availability of noninvasive surgical alternatives and rising awareness
among consumers. According to the International Society of Aesthetic Plastic
Surgery (ISAPS), in 2017, hyaluronic acid-based dermal filler procedures were
among the three most preferred noninvasive aesthetic surgeries.
Minimal adverse effects,
lesser pain, shorter recovery time, and fewer postsurgical complications are
some of the factors driving preference for minimally invasive surgeries. The
European market is dominated by well-known brands such as Juvederm, Restylane,
and Belotero. In addition, France has several native brands with different
patented technologies, thereby contributing to regional market growth. Stylage,
Cytosial, Hyaluronica, and Surface Volume are some of the local brands
available in the market.
Increasing demand for
aesthetic procedures majorly in Italy and Spain is creating a great opportunity
for market expansion. According to the ISAPS, about 952,830 aesthetic surgeries
were performed in 2016, of which 650,995 were noninvasive procedures such as
Botox and dermal fillers.
Various strategic
initiatives such as product launch, approvals, and mergers and acquisitions
propel the market. For instance, in January 2017, Allergan plc launched
Juvederm VOLITE, a new hyaluronic acid dermal filler with its unique patented
VYCROSS technology, which lasts for up to nine months. In another instance, in
September 2018, Allergan acquired Bonti, Inc. to expand its product portfolio
with Bonti’s pipeline products such as (BoNT/E) botulinum neurotoxin serotype E
in phase II, EB-001T (therapeutic), and EB-001A (aesthetic).
Browse full research report on Europe Hyaluronic Acid Based Dermal Fillers Market: https://www.grandviewresearch.com/industry-analysis/europe-hyaluronic-acid-based-dermal-fillers-market
Further key findings from the report
suggest:
- Increase in per capita income in
countries such as Germany, Italy, France, and Spain is a key factor
driving the adoption of dermal fillers. Rapid advancements in dermal
filler technology have resulted in better results in lesser time and at
lower costs
- In 2018, single-phase products
dominated the market owing to technological advancements, wide range of
applications, and rise in applications of implantable devices
- By application, the wrinkle removal
segment is anticipated to grow at the fastest rate during the forecast
period. Hyaluronic acid dermal fillers are gaining popularity in varied
antiaging treatments as they help save time. A general hyaluronic acid anti-wrinkle
treatment procedure takes less than an hour and the average cost is
approximately USD 600
- Italy dominated the regional market
in 2018 owing to technological advancements in the region and introduction
of new products by prominent manufacturers
- Some of the key players in this
industry are Allergan; Galderma Laboratories; Merz Pharma; Genzyme
Corporation; Medicis Pharmaceutical; Inamed Corporation; Anika
Therapeutics, Inc.; Laboratoires VIVACY; Bioxis Pharmaceuticals; and Bohus
Biotech AB.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/europe-hyaluronic-acid-based-dermal-fillers-market/request/rs1
Grand View Research has segmented the Europe
hyaluronic acid based dermal fillers market based on product, application, and
region:
Europe Hyaluronic Acid Based Dermal
Fillers Product (Revenue, USD Million, 2015 - 2026)
- Single-phase
Products
- Duplex
Products
Europe Hyaluronic Acid Based Dermal
Fillers Application Outlook (Revenue, USD Million, 2015 - 2026)
- Wrinkle
Removal
- Lip
Augmentation
- Rhinoplasty
- Others
Europe Hyaluronic Acid Based Dermal
Fillers Country Outlook (Revenue, USD Million, 2015 - 2026)
- U.K.
- France
- Germany
- Italy
- Spain
About
Grand View Research
Grand View Research, Inc.
is a U.S. based market research and consulting company, registered in the State
of California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment